logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Bisphosphonate labelling updates in Canada

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2012年 / 1384卷 / 1期
关键词:
Public Health; Osteoporosis; Bisphosphonate; Healthcare Professional; Femur Fracture;
D O I:
10.2165/00128415-201213840-00004
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [1] Tequin: labelling updates in US, warnings in Canada
    Reactions Weekly, 2006, 1090 (1) : 3 - 3
  • [2] Health Canada updates labelling for diltiazem (Cardizem CD)
    Reactions Weekly, 2018, 1701 (1) : 1 - 1
  • [3] Azithromycin: labelling updates in Malaysia
    Reactions Weekly, 2016, 1624 (1) : 1 - 1
  • [4] US FDA updates bisphosphonate labels
    Reactions Weekly, 2010, 1324 (1) : 2 - 2
  • [5] Safety updates to Canadian labelling for Duragesic
    Reactions Weekly, 2005, 1070 (1) : 2 - 2
  • [6] Safety updates to US labelling for Avinza
    Reactions Weekly, 2005, 1077 (1) : 2 - 2
  • [7] Promethazine hydrochloride injection labelling updates
    Reactions Weekly, 2024, 1990 (1) : 4 - 4
  • [8] Nicorandil (Ikorel): new updates to labelling in Ireland
    Reactions Weekly, 2015, 1581 (1) : 9 - 9
  • [9] US FDA approves Acetadote labelling updates
    Reactions Weekly, 2006, 1093 (1) : 3 - 3
  • [10] Safety updates to US labelling for WinRho SDF
    Reactions Weekly, 2006, 1084 (1) : 2 - 2
← 12345 →